Dexamethasone and CD300a activation display additive inhibitory effect on human and murine mast cell functions

Clin Exp Allergy. 2021 Oct;51(10):1383-1386. doi: 10.1111/cea.13872. Epub 2021 May 7.

Authors

Pratibha Gaur¹, Fidan Rahimli Alekberli¹, Laila Karra¹, David Mankuta², Micha Ben-Zimra¹, Francesca Levi-Schaffer¹

Affiliations

¹ Pharmacology & Experimental Therapeutics Unit, Faculty of Medicine, School of Pharmacy, Institute for Drug Research, Hebrew University of Jerusalem, Jerusalem, Israel.
² Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

PMID: 33797117
DOI: 10.1111/cea.13872

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Antigens, CD
Dexamethasone / pharmacology
Humans
Mast Cells*
Mice
Receptors, Immunologic*

Substances

Antigens, CD
CD300A protein, human
Receptors, Immunologic
Dexamethasone

Grants and funding

Aimwell charitable trust, UK